Hypertrophic osteoarthropathy

被引:44
作者
Martinez-Lavin, Manuel [1 ]
机构
[1] Natl Inst Cardiol, Chief Rheumatol Dept, Juan Badiano 1, Mexico City 14080, DF, Mexico
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2020年 / 34卷 / 03期
关键词
Hypertrophic osteoarthropathy; Digital clubbing; Vascular endothelial growth factor; Prostaglandins; Periostitis; ENDOTHELIAL GROWTH-FACTOR; PATHOGENESIS; SECONDARY;
D O I
10.1016/j.berh.2020.101507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic osteoarthropathy (HOA) is an orphan syndrome characterized by abnormal proliferation of the skin and osseous tissues at the distal parts of the extremities. The main clinical features are: a peculiar bulbous deformity of the tips of the digits conventionally described as "clubbing," periosteal proliferation of the tubular bones, and synovial effusions. In most instances, HOA develops a reaction to a severe internal illness, such as lung cancer, cyanotic heart disease, or liver cirrhosis. There is a subgroup of patients who do not have underlying pathology. Such cases are classified as having primary HOA. Digital clubbing is easy to recognize. Any patient with newly developed digital clubbing should undergo careful search for an underlying illness with special attention to intra-thoracic pathologies. Painful HOA is treated with non-steroidal anti-inflammatory medications. Vascular endothelial growth factor and prostaglandin E2 have been proposed as key bone proliferating mediators. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页数:8
相关论文
共 33 条
[1]   Hypertrophic osteoarthropathy secondary to vascular prosthesis infection -: Report of 3 cases and review of the literature [J].
Alonso-Bartolome, Pilar ;
Martinez-Taboada, Victor Manuel ;
Pina, Trinitario ;
Blanco, Ricardo ;
Rodriguez-Valverde, Vicente .
MEDICINE, 2006, 85 (03) :183-191
[2]   Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing [J].
Atkinson, S ;
Fox, SB .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :721-728
[3]  
BAMBERGER E, 1891, Z KLIN MED, V18, P193
[4]  
DICKINSON CJ, 1987, LANCET, V2, P1434
[5]   Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literature [J].
Elmore, Stephen ;
Wisse, Amy ;
Chapin, Russell W. ;
Whelan, Timothy P. ;
Silver, Richard M. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (02) :319-323
[6]   Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period [J].
Fatourechi, V ;
Ahmed, DDF ;
Schwartz, KM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12) :5435-5441
[7]   Treatment of Hypertrophic Osteoarthropathy with Zoledronic Acid: Case Report and Review of the Literature [J].
Jayakar, Bijal A. ;
Abelson, Abby G. ;
Yao, Qingping .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) :291-296
[8]   Periostitis Secondary to Prolonged Voriconazole Therapy in a Lung Transplant Recipient [J].
Lustenberger, David P. ;
Granata, Jaymes D. ;
Scharschmidt, Thomas J. .
ORTHOPEDICS, 2011, 34 (11) :E793-E796
[9]  
Marie P., 1890, REV MED, V10, P1
[10]  
Martinez-Lavin M, 1994, CARDIOL YOUNG, V4, P228